Hansa Biopharma AB (publ)

BATS-CHIXE:HNSAS Stock Report

Market Cap: SEK 2.9b

Hansa Biopharma Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Renee Aguiar-Lucander

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenure3.3yrs

Recent management updates

Recent updates

CEO

Renee Aguiar-Lucander (63 yo)

less than a year
Tenure

Mrs. Renée Aguiar-Lucander is Director of AC Immune SA. She is Independent Director of Inventiva S.A. from May 22, 2025. Mrs. Aguiar-Lucander has been Chief Executive Officer of Hansa Biopharma AB (publ) s...

Leadership Team

NamePositionTenureCompensationOwnership
Renee Aguiar-Lucander
Chief Executive Officerless than a yearno datano data
C. Ballantyne
CFO & Senior VP1.5yrsno datano data
Monika Tornsen
COO & President of U.S.less than a yearno datano data
Hitto Kaufmann
Senior VP & Chief Scientific and Technology Officer1.8yrsno datano data
Eva-Maria Joed
Vice President of Finance & Administration6.3yrsno datano data
Klaus Sindahl
VP & Head of Investor Relationsno datano datano data
Brian Gorman
Chief Legal Officer and Corporate Secretaryless than a yearno datano data
Sandra Frithiof
Chief Human Resources Officerless than a yearno datano data
Emanuel Björne
VP & Head of Business Developmentno datano datano data
Lena Winstedt
Head of Scienceno datano datano data
Vincenza Nigro
VP & Head of Medical Affairsno datano datano data
Magnus Korsgren
VP & Head of Research and Development4.4yrsno datano data
1.0yrs
Average Tenure
55.5yo
Average Age

Experienced Management: HNSAS's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Mats Blom
Independent Director6.3yrsSEK 493.00k0.0012%
SEK 34.7k
Peter Nicklin
Independent Chairman of the Board3.3yrsSEK 1.14m0.049%
SEK 1.4m
Eva Nilsagard
Independent Director6.3yrsSEK 591.00k0.0035%
SEK 104.0k
Michael Bologna
Directorno datano datano data
Hilary Malone
Independent Director4.3yrsSEK 725.00kno data
Gunnar Tufveson
Chairman of European Medical Advisory Board in Transplantationno datano datano data
Kathryn Wood
Member - European Medical Advisory Board-Transplantation & US Medical Advisory Board-Transplantationno datano datano data
Christophe Legendre
Member of European Medical Advisory Board in Transplantationno datano datano data
Stanley Jordan
Chairman of US Medical Advisory Board in Transplantationno datano datano data
Robert Montgomery
Member of US Medical Advisory Board in Transplantationno datano datano data
Natalie Berner
Directorno datano datano data
Jonas Wikstrom
Independent Director1.3yrsno data0.43%
SEK 12.5m
3.3yrs
Average Tenure
60yo
Average Age

Experienced Board: HNSAS's board of directors are considered experienced (3.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/09/21 01:21
End of Day Share Price 2025/06/25 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hansa Biopharma AB (publ) is covered by 14 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Christian LeeABG Sundal Collier Sponsored
Madhu KumarB. Riley Securities, Inc.